What stimulant and dosing regimen is recommended for an adult with ADHD and co‑existing depression?

Stimulant Treatment for ADHD with Comorbid Depression

Start with a stimulant trial first for adults with ADHD and comorbid depression, unless the depression is severe with psychosis, suicidality, or severe neurovegetative signs. 1

Treatment Algorithm

Step 1: Assess Depression Severity

• If depression is primary or severe (psychotic features, active suicidality, severe neurovegetative symptoms): Treat the major depressive disorder first before addressing ADHD 1

• If depression is less severe or not primary: Proceed directly with stimulant trial, as ADHD symptom reduction often substantially improves depressive symptoms 1

Step 2: Initiate Stimulant Therapy

Starting doses for adults: 1

• Methylphenidate (MPH): Start 5 mg twice daily (morning after breakfast, noon after lunch)
• Dextroamphetamine/Mixed amphetamine salts (DEX/AMP): Start 2.5 mg once daily in early morning, add noon dose if needed

Titration schedule: 1

• Increase weekly by 5-10 mg increments for MPH or 2.5-5 mg for DEX/AMP
• Monitor symptoms and side effects at each increment via phone or office visit
• Continue titration until symptoms resolve or side effects become problematic

Maximum doses for adults: 1

• MPH: Up to 60-65 mg total daily dose (some patients may require up to 1.0 mg/kg)
• DEX/AMP: Up to 40 mg total daily dose (some patients may require up to 0.9 mg/kg)
• Higher doses may be needed to cover longer adult workdays 1

Step 3: Reassess After Stimulant Trial

If both ADHD and depression improve: Continue stimulant monotherapy without additional changes 1

If ADHD improves but depression persists: 1

• Add psychotherapy (cognitive behavioral therapy or interpersonal therapy)
• Consider adding an antidepressant (SSRI such as fluoxetine or sertraline)
• Note: No single antidepressant treats both ADHD and depression effectively 1

If inadequate response to first stimulant: Switch to alternative stimulant (approximately 70% respond to either MPH or DEX alone; nearly 90% respond if both are tried) 1

Combination Therapy Considerations

When combining stimulants with antidepressants: 2

• SSRIs (fluoxetine 10 mg or sertraline 25 mg starting doses) can be safely combined with stimulants
• Stimulants do not provide antidepressant effects; both medications are needed to address each condition separately
• This combination is well-tolerated with minimal cardiovascular effects in most patients
• Monitor blood pressure and heart rate at each visit

Key Clinical Pearls

Advantages of stimulant-first approach: 1

• Rapid onset allows quick assessment of ADHD symptom response (unlike delayed response with nonstimulants)
• Reducing ADHD-related morbidity often substantially improves depressive symptoms
• Allows clearer evaluation of residual depression after ADHD is controlled

Common pitfalls to avoid: 1

• Do not assume comorbid depression contraindicates stimulants—proceed with trial unless depression is severe
• Do not rely solely on patient self-report in adults; obtain collateral information from significant others when possible
• Do not prescribe stimulants to adults with active substance abuse disorder without careful risk assessment 1

Monitoring requirements: 1

• Weekly contact (phone or office) during titration phase (typically 2-4 weeks)
• Assess target ADHD symptoms and depressive symptoms separately at each contact
• Monitor specific side effects: insomnia, anorexia, headaches, anxiety, weight loss
• Measure blood pressure, pulse, and weight at office visits

Formulation considerations for adults: 1

• Long-acting preparations may improve adherence and provide coverage for full workday
• Immediate-release formulations allow more flexible dosing but require multiple daily doses
• Consider patient preference, work schedule, and privacy concerns when selecting formulation